US allows pharmacists to prescribe Pfizer’s COVID-19 pill

WASHINGTON – Pharmacists can prescribe the leading COVID-19 pill directly to patients under a new U.S. guideline announced Wednesday that aims to expand the use of Pfizer’s drug Paxlovid.

The Food and Drug Administration said pharmacists could start screening patients to see if they’re eligible for Paxlovid, then prescribe the drug shown to curb the worst effects of COVID-19. Previously, only doctors could prescribe the antiviral drug.

The announcement comes as COVID-19 cases, hospitalizations and deaths are on the rise again, although they remain near the lowest levels since the coronavirus outbreak began in 2020.

Biden administration officials have expressed frustration that despite the availability of vaccines and treatments, several hundred Americans continue to die from COVID-19 every day.

Administrative officials have been working for months to improve access to Paxlovid. Opening thousands of websites where positively tested patients can fill out a prescription for Paxlovid. FDA change will allow thousands more pharmacies to quickly prescribe and dispense the pill, which must be used early to be effective.


“Because Paxlovid must be taken within five days of symptom onset, allowing state-licensed pharmacists to prescribe Paxlovid could expand access to timely treatment,” Patrizia Cavazzoni, director of the FDA’s Drug Center, said in a statement.

However, paperwork requirements could limit its use. Patients are expected to bring their current medical records — including blood tests — and a list of their current medications so pharmacists can review health conditions and medications that may negatively interact with Paxlovid. Alternatively, pharmacists can consult the patient’s doctor.

Paxlovid is for people with COVID-19 who are more likely to become seriously ill. This includes the elderly and people with other health conditions that make them more vulnerable, such as heart disease, obesity, cancer or diabetes. It is not recommended for patients with severe kidney or liver problems. A course consists of three tablets twice a day for five days.


The FDA approved Paxlovid last December 12 years and older, based on results showing hospital admissions and deaths were reduced by almost 90% in unvaccinated patients, who are most likely to develop serious illness. The drug has shown less impressive results in patients who are already vaccinated, and some doctors have reported it Cases of recurrent COVID-19 symptoms after treatment with the drug.

Extending the test-to-treat program to pharmacists could add thousands of additional options for patients. The two largest US drugstore chains – CVS Health and Walgreens – together operate around 19,000 branches.

CVS Health is already providing COVID-19 care at 1,100 drugstore clinic locations.


There are also nearly 19,400 independent pharmacies that are not affiliated with a major chain, according to the National Community Pharmacists Association.

Pharmacist Michele Belcher said before the announcement she hopes to be able to test customers for COVID-19 and offer the pill because of a shortage of family doctors in her community, the small town of Grants Pass in southwest Oregon.

Belcher said she’s concerned some people might have a hard time getting a doctor’s appointment for a prescription during the tight window to start the pill.

Belcher, owner of the independent Grants Pass Pharmacy, said she used to test and treat COVID-19 with injectable drugs that are no longer as effective.

Her pharmacy routinely checks for potentially harmful drug interactions with other medications a patient may be taking, she said.

“Pharmacists are the drug experts,” she said. “We do that every day, all day, to make sure there are no drug interactions.”



Murphy reported from Indianapolis.


The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute’s Department of Science Education. The AP is solely responsible for all content.

Copyright 2022 The Associated Press. All rights reserved. This material may not be published, broadcast, transcribed or redistributed without permission.

https://www.local10.com/business/2022/07/06/us-allows-pharmacists-to-prescribe-pfizers-covid-pill/ US allows pharmacists to prescribe Pfizer’s COVID-19 pill

Sarah Y. Kim

InternetCloning is an automatic aggregator of the all world’s media. In each content, the hyperlink to the primary source is specified. All trademarks belong to their rightful owners, all materials to their authors. If you are the owner of the content and do not want us to publish your materials, please contact us by email – admin@internetcloning.com. The content will be deleted within 24 hours.

Related Articles

Back to top button